Antineuronal antibodies in patients having myasthenia gravis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000690:Amyotrophic Lateral Sclerosis / Q000276:immunology; D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000032:analysis*; D001327:Autoimmune Diseases / Q000276:immunology; D002525:Cerebellar Cortex / Q000276:immunology; D002531:Cerebellum / Q000276:immunology; D005260:Female; D005452:Fluoresceins; D005455:Fluorescent Antibody Technique; D006801:Humans; D007668:Kidney / Q000276:immunology; D008099:Liver / Q000276:immunology; D008297:Male; D009103:Multiple Sclerosis / Q000276:immunology; D009132:Muscles / Q000276:immunology; D009157:Myasthenia Gravis / Q000276:immunology*; D009474:Neurons / Q000276:immunology*; D010053:Ovary / Q000276:immunology; D011689:Purkinje Cells / Q000276:immunology; D051381:Rats; D013116:Spinal Cord / Q000276:immunology; D013127:Spinal Nerves / Q000276:immunology; D013154:Spleen / Q000276:immunology; D013737:Testis / Q000276:immunology; D013966:Thyroiditis / Q000276:immunology; D005719:gamma-Globulins
D000888:Antibodies, Anti-Idiotypic; D005452:Fluoresceins; D005719:gamma-Globulins